Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSareum Share News (SAR)

Share Price Information for Sareum (SAR)

Share Price is delayed by 15 minutes
Get Live Data
23.00    -0.50 (-2.13%)
Bid:
22.00
Ask:
24.00
Spread: 2.00 (9.091%)
Market Cap: £31.87m
SAR Live PriceLast checked at - London Stock Exchange

Intraday Sareum Share Chart

Sareum News

Sareum falls after safety study halted over animal welfare concerns
10 Oct 2025

Sareum falls after safety study halted over animal welfare concerns

(Alliance News) - Sareum Holdings PLC on Friday said it has ended a study of its drug SDC-1801 after safety issues observed in animals involved in the...

AIM WINNERS & LOSERS: Sareum halts study over control group issues
10 Oct 2025

AIM WINNERS & LOSERS: Sareum halts study over control group issues

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Friday.

Sareum halts toxicology study after control-group safety findings
10 Oct 2025

Sareum halts toxicology study after control-group safety findings

(Sharecast News) - Clinical-stage biotechnology firm Sareum said on Friday that it has discontinued its 16-week pre-clinical toxicology study for auto...

Sareum shares climb on partnership with AI-driven drug discovery firm
12 Aug 2025

Sareum shares climb on partnership with AI-driven drug discovery firm

(Alliance News) - Sareum Holdings PLC on Tuesday reported a strategic collaboration with AI-driven drug discovery firm, Receptor.AI, as it looks to ac...

Sareum starts toxicology studies for lead inhibitor
29 May 2025

Sareum starts toxicology studies for lead inhibitor

(Sharecast News) - Sareum announced the start of a programme of toxicology studies on Thursday, for its lead TYK2/JAK1 inhibitor - SDC-1801 - marking ...

DIRECTOR DEALINGS: Roadside Real Estate chair ups stake toward 26%
27 Mar 2025

DIRECTOR DEALINGS: Roadside Real Estate chair ups stake toward 26%

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Thursday and not separate...

AIM WINNERS & LOSERS: Strong 2024 for Quadrise and Rosebank
31 Dec 2024

AIM WINNERS & LOSERS: Strong 2024 for Quadrise and Rosebank

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

Sareum served notice on commercial licence for cancer treatment
31 Dec 2024

Sareum served notice on commercial licence for cancer treatment

(Alliance News) - Sareum Holdings PLC on Tuesday said a biopharma company in the US has served notice to terminate a development & commercialisation l...